The Industrial Biostructures America conference will take place on May 5 & 6, 2025 at the MassBioHub in Cambridge MA. The conference was launched in 2018 to bring the industry-based structural biology community together for two days of presentations and networking. This is a great place for industrial structural biologists, as well as those who are industry-curious. The conference will feature keynote presentations by:

 

• Dr. Stephen K. Burley, Director RCSB Protein Data Bank and Rutgers University Professor

• Dr. James Fraser, Professor and Chair Department of Bioengineering and Therapeutics Sciences at UCSF

• Dr. Stephen Harrison, Professor Harvard Medical School/Investigator Howard Hughes Medical Institute

• Dr. Mark Murcko, Founding CSO/Board Member at Dewpoint Therapeutics and Relay Therapeutics

 

Conference information is available at https://industrialbiostructuresamerica.org along with guidelines for submitting abstracts for scientific presentations during the conference. Scientific sessions will cover the following topics:

 

• Structural Biology of Targeted Protein Degradation: Glues, TCs & DUBs

• Developing Fragments to Drugs: Challenges & Victories

• Molecular Dynamics and Allostery – Bridging Experimental and Computational Drug Discovery

• Membrane Protein Structure Guided Design

• CryoEM Synergies with Molecular Modeling and Computational Models

• Biologics (Antibody Design & ADCs)

• AI/ML in Structural Biology and Drug Discovery

• Hot Topics (SBDD, Kinases, RNA)

 

The abstract deadline is April 1. Space is limited so if you're interested, please register soon.

 

Contact us at [email protected] for information regarding Exhibitor and Sponsor opportunities

 


logo.png
Charles Lesburg
Vice President, Structural Biology
odysseytx.com
This message is for the named person's use only. It may contain confidential, proprietary or legally privileged information. If you receive this message in error, please immediately delete it and all copies of it from your system, destroy any hard copies of it and notify the sender. ODYSSEY THERAPEUTICS, INC. ("ODYSSEY THERAPEUTICS") reserves the right to monitor all e-mail communications through its networks. ODYSSEY THERAPEUTICS cannot be committed by this e-mail or warrant the accuracy or validity of any information presented. Any views expressed in this message are those of the individual sender.